Molecule Name |
DB00466
|
DrugBank Groups |
Experimental
|
Cluster No |
1
|
Smiles |
O=C1(OC4(C5(OC(=O)C(C3(C4(C12(OC2C3))(C))(O))C5C(O)(C)C)))
|
Download |
mol2, pdbqt
|
TPSA |
186,53
|
Non-H Atoms |
22
|
Non-C/H Atoms |
7
|
Metal-Atoms |
0
|
Electronegative Atoms |
7
|
Stereo Centers |
8
|
Rotatable Bonds |
1
|
Rings Closures |
5
|
Small Rings |
7
|
Aromatic Rings |
0
|
Aromatic Atoms |
0
|
sp3-Atoms |
18
|
Symmetric atoms |
1
|
cLogS |
-1,759
|
MW |
310,301
|
cLogP |
-1,7499
|
HBA |
7
|
HBD |
2
|
Ro5 violations |
0
|
Druglikeness |
1,0596
|
DrugScore |
0,488779558261595
|
Mutagenic |
none
|
Tumorigenic |
none
|
Reproductive Effective |
none
|
Irritant |
high
|
Blood-Brain Barrier |
BBB+
|
Human Intestinal Absorption |
HIA+
|
Caco-2 Permeability |
Caco2-
|
P-glycoprotein Substrate |
Substrate
|
P-glycoprotein Inhibitor |
Inhibitor
|
P-glycoprotein Inhibitor 2 |
Non-inhibitor
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Aqueous solubility |
-3,4304
|
Caco-2 Permeability 2 |
0,5988
|
Subcellular localization |
Mitochondria
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 2D6 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Substrate
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition 2 |
Non-inhibitor
|
AMES Toxicity |
AMES toxic
|
Carcinogens |
Non-carcinogens
|
Fish Toxicity |
High FHMT
|
Fish Toxicity (pLC50, mg/L) |
1,1943
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity (pIGC50, ug/L) |
0,587
|
Honey Bee Toxicity |
High HBT
|
Biodegradation |
Not ready biodegradable
|
Acute Oral Toxicity |
III
|
Rat Acute Toxicity (LD50, mol/kg) |
2,9546
|
Carcinogenicity (Three-class) |
Non-required
|